NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Fitzgerald Kevin Joseph

Filed: 2026-04-09 AccNo: 0001886431-26-000004 Size: 5 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/09 21:15 UTC
首次发现04/09 21:17 UTC
热度106.3
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 460 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001886431-26-000004

Filing Date: 2026-04-09

Accepted: 2026-04-09 17:15:06

Documents: 1

Period of Report: 2026-04-07

Ovid Therapeutics Inc. ( Issuer ) CIK : 0001636651 (see all company filings) EIN. : 465270895 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | form4-04092026_050401.xml | 4 | 3810